Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · IEX Real-Time Price · USD
0.607
+0.015 (2.53%)
Jun 20, 2024, 3:58 PM EDT - Market closed

Sensei Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018
Net Income
-34.1-48.59-36.79-20.2-20.54
Upgrade
Depreciation & Amortization
2.712.540.690.210.07
Upgrade
Share-Based Compensation
4.455.815.661.491.18
Upgrade
Other Operating Activities
-5.081.210.190.696.92
Upgrade
Operating Cash Flow
-32.02-39.03-30.26-17.71-8.57
Upgrade
Capital Expenditures
-0.01-0.31-1.71-1.21-0.05
Upgrade
Acquisitions
000-0.20
Upgrade
Change in Investments
38.4350.26-141.4100
Upgrade
Investing Cash Flow
38.4149.95-143.12-1.4-0.05
Upgrade
Share Issuance / Repurchase
-10.410.34140.70.020.15
Upgrade
Debt Issued / Paid
-0.76-0.63-0.260.538.07
Upgrade
Other Financing Activities
--23.4934.91-
Upgrade
Financing Cash Flow
-11.17-0.29163.9435.458.22
Upgrade
Net Cash Flow
-4.7810.64-9.4416.35-0.4
Upgrade
Free Cash Flow
-32.04-39.33-31.97-18.91-8.62
Upgrade
Free Cash Flow Per Share
-1.15-1.28-1.15-11.73-23.48
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).